GT Biopharma
GTBP
GTBP
49 hedge funds and large institutions have $69.7M invested in GT Biopharma in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+29
Holders Change %
+145%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
9
Reduced
4
Closed
4
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$9K
Top Buyers
| 1 |
1
BlackRock
New York
|
$21.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$15.2M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$7.91M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$5.81M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.37M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$113K | -551 | Closed |
|
|
SPIA
52
Steward Partners Investment Advisory
New York
| – | -$198 | -1 | Closed |
|